Jeff Yass’s ESSA Pharma EPIX Stock Holding History

Jeff Yass’s Portfolio EPIX Stock Details EPIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-17,704	Closed	-$31.7K	–	12718
2024 Q4	$31.7K	Buy	+17,704	New	+$56.4K	﹤0.01%	11828
2023 Q4	–	Sell	-95,758	Closed	-$472K	–	12575
2023 Q3	$296K	Buy	95,758 +46,228	+93%	+$133K	﹤0.01%	9371
2023 Q2	$134K	Buy	+49,530	New	+$145K	﹤0.01%	10687
2022 Q4	–	Sell	-19,872	Closed	-$57K	–	12729
2022 Q3	$36K	Buy	+19,872	New	+$52.4K	﹤0.01%	12380
2018 Q2	–	Sell	-792	Closed	-$3K	–	9770
2018 Q1	$3K	Sell	792 -2,639	-77%	-$11K	﹤0.01%	9202
2017 Q4	$15K	Buy	+3,431	New	+$17.9K	﹤0.01%	9096

Jeff Yass's EPIX Position: Q1 2025 in Review

Jeff Yass sold out of ESSA Pharma (EPIX) in Q1 2025, closing a stake of 17,704 shares — an estimated $31.7K sold.

Jeff Yass first reported a position in EPIX in Q4 2017 and held it in 6 quarters. The position peaked at $296K in Q3 2023. 36 funds tracked by Wall St. Rank hold EPIX as of Q1 2025.

Jeff Yass reported no remaining ESSA Pharma position as of Q1 2025 after selling out during the quarter.
Jeff Yass sold 17,704 ESSA Pharma shares in Q1 2025, an estimated $31.7K.
Jeff Yass first reported a position in ESSA Pharma in Q4 2017 and held it in 6 quarters.
Jeff Yass's ESSA Pharma position peaked at $296K in Q3 2023.
36 funds tracked by Wall St. Rank held ESSA Pharma as of Q1 2025.

Based on Susquehanna International Group's 13F filing for Q1 2025, filed 14 May 2025.